MedPath

A controlled trial of Casein Phosphopeptide - Amorphous Calcium Phosphate (CPP-ACP) toothpaste in 6 year old childre

Phase 4
Conditions
Dental caries
Oral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon
Registration Number
ACTRN12615001227583
Lead Sponsor
The University of Queensland, School of Dentistry
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Stopped early
Sex
All
Target Recruitment
600
Inclusion Criteria

One or more partially erupted/ erupted first molars
One or more DMFT/ dmft according to the WHO criteria

Exclusion Criteria

- Children with a milk protein allergy
- Children with a benzoate sensitivity
- Children who are participating or have participated in the previous two years to other intervention studies
- Children using topical antimicrobials (except for fluoridated toothpaste)
- Children who have had systemic antibiotics use in the three months prior to baseline
- Children who reside in areas that have a non-fluoridated water supply
- Children who do not complete baseline treatment within 8 weeks
- Edentulous or children with less than 4 teeth
- Children with fixed or removable orthodontic appliances for cleft lip and palate
- Children with severe facial trauma

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath